A new type of peptide receptor radionuclide therapy (PRRT) appears to be safe in metastatic neuroendocrine tumor patients who ...
The way the petroleum resource rent tax (PRRT) is set up means mining usually generates some revenue, on top of the corporate income tax, for the government over the life of projects. However, there ...
During the forecast period, the Peptide Receptor Radionuclide Therapy (PRRT) Market is expected to grow at a strong CAGR of 7.2%. The market is currently worth US$ 552.08 million in 2022 and is ...
The Peptide Receptor Radionuclide Therapy (PRRT) Industry is on a trajectory of exceptional growth, with projections indicating a worth of US$ 591.83 million in 2023 and a substantial leap towards US$ ...
Neuroendocrine cancer is exceedingly difficult to manage and unlikely to be cured, but researchers intend to slow progression of these tumors and aid survival by personalizing patient dose of ...
PRRT changes announced ahead of the budget will raise $7bn over 10 years – but modest measures I suggested last year would have bought in triple that Difficult judgments are required when increasing ...
Peptide receptor radionuclide therapy (PRRT) with lutetium dotatate is a treatment for well-differentiated neuroendocrine tumors that the U.S. Food and Drug Administration approved in 2018, but ...
The extraordinary dodging of both company tax and the Petroleum Resource Rent Tax (PRRT) by Australia’s, and the world’s, biggest gas companies — and thus the theft from Australians of income from our ...
Patients with neuroendocrine tumours are increasingly treated with peptide receptor radionuclide therapy. However, tumour somatostatin receptor expression evaluation cannot accurately predict who will ...
If you’re wondering who is going to pay for Scott Morrison’s $16 billion election war chest of pork, or the massive, seemingly permanent increase in the size of the federal government as a part of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results